Analysts Offer Predictions for Longboard Pharmaceuticals, Inc.'s FY2023 Earnings (NASDAQ:LBPH)

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – HC Wainwright decreased their FY2023 earnings estimates for shares of Longboard Pharmaceuticals in a report issued on Monday, January 8th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of ($2.28) for the year, down from their previous estimate of ($2.14). […]

Related Keywords

California ,United States , ,Nasdaq ,Wells Fargo Company ,Northern Trust Corp ,Manufacturers Life Insurance Company ,Longboard Pharmaceuticals ,Citigroup Inc ,News Ratings For Longboard Pharmaceuticals Daily ,Institutional Investors Weigh In On Longboard Pharmaceuticals ,Longboard Pharmaceuticals Inc ,Cantor Fitzgerald ,Longboard Pharmaceuticals Price Performance ,Free Report ,Longboard Pharmaceutical ,Get Free Report ,Trust Corp ,State Teachers Retirement System ,Wells Fargo ,Longboard Pharmaceuticals Daily ,Nasdaq Lbph ,Lbph ,Medical ,Earnings Estimates ,Hc Wainwright ,